Drugs are being invented and manufactured right here in the U.S. by Americans, for Americans. So why doesn’t the industry ...

The Trump administration's ever-changing tariffs and Most Favored Nation drug pricing are part of a blizzard of unclear, ...

The announcement by President Donald Trump's administration of the results of a probe into pharmaceutical imports and new ...

OpenSecrets reports the pharma industry led lobbying in Q2 2025, spending $105.4 million, followed by Ballard Partners at $20 ...

Unites the Pharma Marketing, PR & Communications, Commercialization and Medical Affairs CommunitiesSeptember 8-11 in ...

Drugmakers generate most of their sales in the U.S. The Pharmaceutical Research and Manufacturers of America - the industry's ...

The strategy clearly defines the goal of turning Vietnam into a centre for high-value pharmaceutical production in the region, ensuring access to drugs at reasonable costs, improving the capacity to ...

Unlike traditional pharmaceutical companies that own and market their products, CFAO Healthcare South Africa operates as a ...

A New Jersey pharmaceutical company filed a lawsuit in federal court last week challenging a new Maine law aimed to protect a ...

The pharmaceutical sector, a beacon of innovation, stands tall in Europe's economic landscape. Yet even a robust industry is not immune to financial challenges.

And pharmaceutical companies spend big on lobbying in Washington — more than any other industry in 2017 — helping to assure victories like the 2003 Medicare Part D legislation which banned the ...

Let's see why the pharmaceutical industry is now in need of innovation more than ever, how it can navigate through the hype around AI and harness value and how long that might take.